All Articles

The pest control specialist's Nasdaq debut is more than a ticker change. It’s a calculated gambit to tap U.S. capital and scale a resilient, niche industry.

As the RWA market accelerates, Auxite’s new platform for gold, silver, platinum, and palladium bets on verifiable ownership over simple price exposure.

Consolidated Water's appointment of Sachin Chawla signals a major strategic shift, leveraging his deep expertise from massive projects to fuel an aggressive expansion.

The firm's high-level hires from rival firms signal a calculated move to dominate the lucrative credit and opportunistic investment landscape amid market shifts.

Griffon Corporation is offloading its AMES Australasia unit, but this is no fire sale. It’s a calculated JV that nets cash now and retains future upside.

With a new $4.3B war chest, Hunter Point Capital is evolving from a GP stakes firm into a scaled solutions platform, meeting a critical need for liquidity.

By becoming the exclusive insurance partner for Huawei's luxury EVs, SunCar is embedding its AI platform deep within a new automotive power structure.

A landmark drug approval in China offers new hope for IgAN patients. But the real story is how science, strategy, and policy are converging to build a better future.

As AI demos flood Automate 2026, Datanomix stands out by proving its AI is already working, democratizing advanced analytics for manufacturers of all sizes.

Conexeu Sciences hits a key manufacturing milestone for its innovative wound-healing gel, but the path to FDA clearance and a crowded market remains a challenge.

HUHUTECH is pivoting from engineering services to building its own semiconductor gear, a move that could reshape its future and tap into China's tech self-sufficiency drive.

While chips get the glory, a Wisconsin firm's strategic play in data center lighting reveals the real, power-hungry infrastructure behind the AI revolution.

A major stock conversion aims to save Alpha Modus from Nasdaq delisting. Is it a savvy financial maneuver or a last-ditch effort for its AI ambitions?

A Berkeley startup is turning old clothes into virgin-quality materials using AI-designed enzymes. This isn't just recycling; it's a new economic model.

As AI pushes data centers to their thermal limits, one company's pivot from product-maker to systems partner reveals the future of mission-critical validation.

Behind every 5G signal and autonomous car are microscopic parts. At IMS 2026, KYOCERA AVX is revealing why these unseen components are the real investment story.

The new collaboration embeds S&P Global's essential data into Cohere's secure AI platform, promising verifiable, agentic workflows for Wall Street.

As outdoor recreation booms, volunteer Search & Rescue teams are stretched thin. A unique corporate pledge offers a sustainable model to fund these vital services.

A new documentary on a Silicon Valley engineer turned cricket hero reveals a calculated strategy: to win America's heart, you must first tell its stories.

Septerna's novel oral drug for hypoparathyroidism could end the tyranny of injections and supplements, but its success hinges on a bigger bet: a new system for drugging life's most difficult molecular targets.